AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18559234 — intervention group
Group type: COMPARATOR
Intervention: Mahuang Zhisou Pill (Control)
Number of subjects: 240
Study 17235418 — intervention group
Group type: EXPERIMENTAL
Intervention: Various drugs including 5‐Methyltetrahydrofolate, 9‐aminocamptothecin, and others
Number of subjects: 0
Study 12825306 — intervention group
Group type: EXPERIMENTAL
Intervention: 27-gauge Whitacre-point needle (group I)
Number of subjects: 1555
Study 12825306 — intervention group
Group type: COMPARATOR
Intervention: 27-gauge Quincke-point needle (group II)
Number of subjects: 1555
Study 10980228 — intervention group
Group type: EXPERIMENTAL
Intervention: P-wave signal-averaged electrocardiogram (SAECG)
Number of subjects: 93
Study 9012325 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate exposure (55.70-87.98 mg/l)
Number of subjects: 70
Study 9012325 — intervention group
Group type: COMPARATOR
Intervention: Control group (nitrate concentration 0.7 mg/l)
Number of subjects: 70
Study 1473544 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique A (60 cycles/min, IT 0.33s, I:E 1:2)
Number of subjects: 181
Study 1473544 — intervention group
Group type: COMPARATOR
Intervention: Technique B (30 cycles/min, IT 1.0s, I:E 1:1 to 2:1)
Number of subjects: 181
Study 1473544 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique A (60 cycles/min, IT 0.33s) in subgroup 31-32 weeks gestation
Number of subjects: 181
Study 1473544 — intervention group
Group type: EXPERIMENTAL
Intervention: Technique A (60 cycles/min, IT 0.33s) in most immature group (< 28 weeks)
Number of subjects: 181
Study 3155742 — intervention group
Group type: EXPERIMENTAL
Intervention: Seven milliliters of methylprednisolone acetate and procaine
Number of subjects: 73
Study 3155742 — intervention group
Group type: EXPERIMENTAL
Intervention: Eighty milligrams of methylprednisolone acetate combined with five milliliters of 1 percent procaine
Number of subjects: 73
Study 3155742 — intervention group
Group type: COMPARATOR
Intervention: Two milliliters of sterile saline combined with five milliliters of 1 percent procaine
Number of subjects: 73
Study 30057033 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with 0.5% Citrus aurantium blossom essential oil
Number of subjects: 62
Study 30057033 — intervention group
Group type: COMPARATOR
Intervention: Control group with inhalation of odorless sweet almond oil
Number of subjects: 62
Study 26918853 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilastine 10 mg
Number of subjects: 509
Study 26918853 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study 23147277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Care (IC)
Number of subjects: 1461
Study 23147277 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1461
Study 22393922 — intervention group
Group type: EXPERIMENTAL
Intervention: New ultrasonic dissector (NUD)
Number of subjects: 261
Study 22393922 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemostasis (CH)
Number of subjects: 261
Study 20045311 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line treatment for advanced NSCLC
Number of subjects: 1239
Study 20045311 — intervention group
Group type: EXPERIMENTAL
Intervention: Best prognostic score category (<5)
Number of subjects: 1239
Study 20045311 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate prognostic score category (5-9)
Number of subjects: 1239
Study 20045311 — intervention group
Group type: EXPERIMENTAL
Intervention: Worst prognostic score category (>9)
Number of subjects: 1239
Study 18532899 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturopathic medicine plus usual care
Number of subjects: 45
Study 18532899 — intervention group
Group type: EXPERIMENTAL
Intervention: MS education plus usual care
Number of subjects: 45
Study 18532899 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 45
Study 15691817 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Problem‐Related Anatomy Demonstrations
Number of subjects: 176
Study 12610743 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg for 14 days
Number of subjects: 18
Study 10536354 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine-needle aspiration (FNA) procedure
Number of subjects: 1196
Study 8934377 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (4 mg daily) plus indapamide (2.5 mg daily)
Number of subjects: 6000
Study 8934377 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for patients without an indication for or contraindication to treatment with a diuretic
Number of subjects: 6000
Study 8934377 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril alone
Number of subjects: 6000
Study 8934377 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo for all other patients
Number of subjects: 6000
Study 8934377 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 6000
Study 1931394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane anaesthesia
Number of subjects: 30
Study 1931394 — intervention group
Group type: COMPARATOR
Intervention: Halothane anaesthesia
Number of subjects: 30
Study 7450409 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10-20 mg sublingually before each meal)
Number of subjects: 20
Study 7450409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31973041 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly text messages with a single item stress question
Number of subjects: 0
Study 31973041 — intervention group
Group type: EXPERIMENTAL
Intervention: High-stress subgroup
Number of subjects: 0
Study 31973041 — intervention group
Group type: EXPERIMENTAL
Intervention: High exhaustion scores
Number of subjects: 0
Study 31973041 — intervention group
Group type: EXPERIMENTAL
Intervention: Objective workload
Number of subjects: 0
Study 30367450 — intervention group
Group type: EXPERIMENTAL
Intervention: Strategy-focused instruction (experimental condition)
Number of subjects: 101
Study 30367450 — intervention group
Group type: COMPARATOR
Intervention: Practice-matched control condition
Number of subjects: 101
Study 28964994 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard weekly therapist support
Number of subjects: 180
Study 28964994 — intervention group
Group type: COMPARATOR
Intervention: Optional weekly therapist support
Number of subjects: 180
Study 25585272 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 60
Study 25585272 — intervention group
Group type: COMPARATOR
Intervention: Applied Relaxation (AR)
Number of subjects: 60
Study 24968576 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Group (EG)
Number of subjects: 25
Study 24968576 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage and Exercise Group (MEG)
Number of subjects: 25
Study 24968576 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 25
Study 21426323 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Knife radiosurgery (RS) at 20 Gy or 24 Gy, 5.5‐7.5 ml at the 50% isodose volume
Number of subjects: 30
Study 21426323 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma Knife radiosurgery (RS)
Number of subjects: 30
Study 19472126 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine sulfate
Number of subjects: 64
Study 19472126 — intervention group
Group type: COMPARATOR
Intervention: Hypertonic saline solution (placebo)
Number of subjects: 64
Study 17410044 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment with 40,000 U of epoetin alfa once weekly at chemotherapy initiation
Number of subjects: 216
Study 17410044 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment with epoetin alfa (no treatment unless Hb decreased to < 10 g/dl)
Number of subjects: 216
Study 17410044 — intervention group
Group type: EXPERIMENTAL
Intervention: Both immediate and delayed groups
Number of subjects: 216
Study 15492149 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic gastric bypass
Number of subjects: 645
Study 15492149 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic vertical banded gastroplasty
Number of subjects: 645
Study 15492149 — intervention group
Group type: EXPERIMENTAL
Intervention: Both surgical interventions
Number of subjects: 645
Study 14679785 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group (mixed green vegetable and fruit beverage containing broccoli and cabbage)
Number of subjects: 77
Study 14679785 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo sample made from the same materials but without broccoli and cabbage)
Number of subjects: 77
Study 14679785 — intervention group
Group type: EXPERIMENTAL
Intervention: Test group
Number of subjects: 77
Study 10203367 — intervention group
Group type: EXPERIMENTAL
Intervention: CML (carboxymethyllysine)
Number of subjects: 0
Study 10203367 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosidine
Number of subjects: 0
Study 10203367 — intervention group
Group type: EXPERIMENTAL
Intervention: MDA-lysine (malondialdehyde-lysine)
Number of subjects: 0
Study 10203367 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-hydroxynonenal-protein adduct
Number of subjects: 0
Study 10203367 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrolein-protein adduct
Number of subjects: 0
Study 10203367 — intervention group
Group type: COMPARATOR
Intervention: MDA-lysine
Number of subjects: 0
Study 10203367 — intervention group
Group type: COMPARATOR
Intervention: CML, Pentosidine, Acrolein-protein adduct
Number of subjects: 0
Study 7760256 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.2 mg/kg)
Number of subjects: 22
Study 7760256 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.4 mg/kg)
Number of subjects: 22
Study 7760256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 2148830 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin plus Medroxyprogesterone acetate (MPA)
Number of subjects: 79
Study 2148830 — intervention group
Group type: COMPARATOR
Intervention: Epirubicin plus placebo
Number of subjects: 79
Study 2148830 — intervention group
Group type: EXPERIMENTAL
Intervention: Estramustine phosphate
Number of subjects: 79
Study 7002179 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75%
Number of subjects: 0
Study 7002179 — intervention group
Group type: EXPERIMENTAL
Intervention: Etidocaine 1.5%
Number of subjects: 0
Study 7002179 — intervention group
Group type: EXPERIMENTAL
Intervention: Prilocaine 3%
Number of subjects: 0
Study 31116967 — intervention group
Group type: EXPERIMENTAL
Intervention: Molecular typing and antibiotic susceptibility testing of K. pneumoniae isolates
Number of subjects: 100
Study 28927680 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Action Plan (DAP)
Number of subjects: 510
Study 28927680 — intervention group
Group type: COMPARATOR
Intervention: Written Action Plan (WAP)
Number of subjects: 510
Study 25670039 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 64
Study 25670039 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 64
Study 24021935 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous femoral nerve blockade
Number of subjects: 60
Study 24021935 — intervention group
Group type: COMPARATOR
Intervention: Conventional patient-controlled analgesia
Number of subjects: 60
Study 21118604 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (20 g for 5 days)
Number of subjects: 128
Study 21118604 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study 19234482 — intervention group
Group type: EXPERIMENTAL
Intervention: Tissue-cultured mountain ginseng extract (TMGE) 1000 mg twice a day
Number of subjects: 143
Study 19234482 — intervention group
Group type: COMPARATOR
Intervention: Placebo 1000 mg twice a day
Number of subjects: 143
Study 17556685 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat snack (30.8% of energy from fat, 5.2% of energy from PUFAs)
Number of subjects: 33
Study 17556685 — intervention group
Group type: EXPERIMENTAL
Intervention: High-PUFA snack (36.3% of energy from fat, 9.7% of energy from PUFAs)
Number of subjects: 33
Study 17556685 — intervention group
Group type: COMPARATOR
Intervention: High-fat snack (37.9% of energy from fat, 5.8% of energy from PUFAs)
Number of subjects: 33
Study 15235386 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab alone
Number of subjects: 22
Study 15235386 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus thalidomide
Number of subjects: 22
Study 11585273 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial support for early breast cancer patients
Number of subjects: 84
Study 11585273 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial support for advanced breast cancer patients
Number of subjects: 84
Study 9647684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rote serial-order memory task
Number of subjects: 10
Study 9647684 — intervention group
Group type: EXPERIMENTAL
Intervention: Elaborative category memory task
Number of subjects: 10
Study 9647684 — intervention group
Group type: COMPARATOR
Intervention: High recallers
Number of subjects: 10
Study 9647684 — intervention group
Group type: COMPARATOR
Intervention: Low recallers
Number of subjects: 10
Study 7926494 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg once daily
Number of subjects: 392
Study 7926494 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg once daily
Number of subjects: 392
Study 7926494 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg twice daily
Number of subjects: 392
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal n-3 PUFA levels
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal DHA levels
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin births
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Birth weight in kilograms
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal n-6 PUFA levels
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal MUFA levels
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal MUAC
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 238
Study 31024091 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal plasma AA levels
Number of subjects: 238
Study 31578141 — intervention group
Group type: EXPERIMENTAL
Intervention: VENUSS prognostic model
Number of subjects: 556
Study 27641918 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency neurolysis
Number of subjects: 28
Study 27641918 — intervention group
Group type: COMPARATOR
Intervention: Local anesthetic and corticosteroid block
Number of subjects: 28
Study 26279196 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT) with 4 × 2 minutes of bilateral dynamic squat exercises on a side‐alternating vibration platform at 24 to 26 Hz
Number of subjects: 83
Study 26279196 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON) with the same amount of exercise time on the floor
Number of subjects: 83
Study 26279196 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 83
Study 26279196 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 83
Study 22902255 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance exercise with whole-body vibration (WBV+RE)
Number of subjects: 10
Study 22902255 — intervention group
Group type: COMPARATOR
Intervention: High-intensity resistance exercise (RE)
Number of subjects: 10
Study 20652398 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunitinib (arm A)
Number of subjects: 55
Study 20652398 — intervention group
Group type: COMPARATOR
Intervention: No therapy (arm B)
Number of subjects: 55
Study 18204125 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled inhalation of tobramycin (150 mg, twice daily for three days)
Number of subjects: 16
Study 18204125 — intervention group
Group type: COMPARATOR
Intervention: Conventional inhalation of tobramycin (300 mg, twice daily for three days)
Number of subjects: 16
Study 15572485 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Burch colposuspension
Number of subjects: 72
Study 15572485 — intervention group
Group type: COMPARATOR
Intervention: Tension-free vaginal tape (TVT)
Number of subjects: 72
Study 15572485 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study 11822351 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 65
Study 11822351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 10212857 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide inhaler exhaled through the nose
Number of subjects: 49
Study 10212857 — intervention group
Group type: COMPARATOR
Intervention: Combination of budesonide metered dose inhaler with budesonide nasal spray
Number of subjects: 49
Study 8847426 — intervention group
Group type: EXPERIMENTAL
Intervention: 41/min oxygen in 35 patients
Number of subjects: 78
Study 8847426 — intervention group
Group type: COMPARATOR
Intervention: No supplemental oxygen therapy
Number of subjects: 78
Study 2215824 — intervention group
Group type: EXPERIMENTAL
Intervention: Plax
Number of subjects: 10
Study 2215824 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 10
Study 111293 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverage
Number of subjects: 64
Study 111293 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage
Number of subjects: 64
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% linseed oil (LO)
Number of subjects: 96
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing dietary LO (1%, 2%, 4%)
Number of subjects: 96
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% linseed oil (LO)
Number of subjects: 96
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% and 2% linseed oil (LO)
Number of subjects: 96
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% and 4% linseed oil (LO)
Number of subjects: 96
Study 30925360 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding linseed oil (LO) in diets
Number of subjects: 96
Study 28751002 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracorporeal purse string suture ligation of the hernia sac at internal inguinal ring (IIR) leaving the sac intact
Number of subjects: 132
Study 28751002 — intervention group
Group type: COMPARATOR
Intervention: Disconnection of the hernia sac with intracorporeal suturing of proximal part at IIR
Number of subjects: 132
Study 25835747 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Flexible Sigmoidoscopy (FSG)
Number of subjects: 21925
Study 23524696 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 75 mg
Number of subjects: 143
Study 23524696 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 150 mg
Number of subjects: 143
Study 23524696 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 143
Study 21372609 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (I) - School-based intervention including six nutrition units and 20-min running games in the first year.
Number of subjects: 1192
Study 21372609 — intervention group
Group type: COMPARATOR
Intervention: Non-Intervention (NI) - Control group with no intervention.
Number of subjects: 1192
Study 21372609 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (I) in high socio-economic status (SES) students.
Number of subjects: 1192
Study 21372609 — intervention group
Group type: COMPARATOR
Intervention: Non-Intervention (NI) in high socio-economic status (SES) students.
Number of subjects: 1192
Study 20040088 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Action Plan (AP) intervention
Number of subjects: 245
Study 20040088 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 245
Study 17192768 — intervention group
Group type: EXPERIMENTAL
Intervention: Depo-medroxyprogesterone acetate (DMPA)
Number of subjects: 70
Study 17192768 — intervention group
Group type: COMPARATOR
Intervention: Nelfinavir
Number of subjects: 70
Study 17192768 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 70
Study 17192768 — intervention group
Group type: COMPARATOR
Intervention: Nevirapine
Number of subjects: 70
Study 17192768 — intervention group
Group type: EXPERIMENTAL
Intervention: DMPA
Number of subjects: 70
Study 15174909 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 25
Study 15174909 — intervention group
Group type: COMPARATOR
Intervention: Carotid Artery Stenting (CAS)
Number of subjects: 25
Study 11755836 — intervention group
Group type: EXPERIMENTAL
Intervention: Grading by trained technicians of horizontal cup/disk ratio from optic disk stereophotographs
Number of subjects: 1636
Study 11755836 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimates of horizontal cup/disk ratio from sequential full-frame photographs
Number of subjects: 1636
Study 11755836 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradings by technicians
Number of subjects: 1636
Study 9840600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (anthelmintic)
Number of subjects: 336
Study 9840600 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education
Number of subjects: 336
Study 9840600 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole and health education
Number of subjects: 336
Study 9840600 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 336
Study 9840600 — intervention group
Group type: COMPARATOR
Intervention: Egg-negative children (control)
Number of subjects: 336
Study 8084436 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitonin and arginine-lysine-glycerophosphoric acid-lactose association
Number of subjects: 2
Study 8084436 — intervention group
Group type: COMPARATOR
Intervention: Calcitonin
Number of subjects: 2
Study 2510877 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide (12.5 mg, increased to 25 mg if needed)
Number of subjects: 369
Study 2510877 — intervention group
Group type: COMPARATOR
Intervention: Sustained release verapamil (120 mg, increased to 240 mg if needed)
Number of subjects: 369